© 2022 MJH Life Sciences™ and Modern Retina. All rights reserved.
Cheryl Guttman Krader, BS, Pharm
Articles
Nanotechnology strategies explored as novel therapeutic approach to photoreceptor blindness
October 27, 2018
Article
Treat-and-extend protocol reduces burden of anti-VEGF treatment for DME
January 17, 2018
Article
Results of the prospective TREX-DME study provide an evidence base for using a treat-and-extend protocol for administering anti-VEGF injections for eyes with diabetic macular edema.
Suprachoroidal corticosteroid shows visual, anatomic improvements in DME eyes
January 11, 2018
Article
Suprachoroidal triamcinolone acetonide (CLS-TA, Clearside Biomedical) injection resulted in visual and anatomic improvements in eyes with diabetic macular edema, particularly in those that were treatment-naïve. Multiple injections of the investigational treatment were well-tolerated and associated with a low incidence of IOP elevation.
Study finds no VA benefit by adding corticosteroid implant to anti-VEGF injections
December 20, 2017
Article
VMA associated with poor outcomes in anti-VEGF-treated patients
July 20, 2017
Article
The presence of vitreomacular adhesion (VMA) is associated with poorer, short-term anatomic, and functional outcomes in eyes with diabetic macular edema (DME) receiving anti-VEGF therapy, according to Márcio B. Nehemy, MD, PhD.